Explaining variations in prescribing costs across England.
about
Exploring the equity of GP practice prescribing rates for selected coronary heart disease drugs: a multiple regression analysis with proxies of healthcare needA comparison of three methods of setting prescribing budgets, using data derived from defined daily dose analyses of historic patterns of use.The quality of prescribing in general practice.Controversies in primary care. Setting prescribing budgets in general practice. Effective prescribing at practice level should be identified and rewardedUsing unemployment rates to predict prescribing trends in England.Investigation of whether on-site general practice counsellors have an impact on psychotropic drug prescribing rates and costs.Morbidity, deprivation, and antidepressant prescribing in general practice.Do GPs working in practice with high or low prescribing costs have different views on prescribing cost issues?Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional surveyWhat variables should be considered in allocating Primary health care Pharmaceutical budgets to districts in Uganda?Differential associations between actual and expected GP practice prescribing rates for statins, ACE inhibitors, and beta-blockers: a cross-sectional study in EnglandAre GP practice prescribing rates for coronary heart disease drugs equitable? A cross sectional analysis in four primary care trusts in England.Predictors of primary health care pharmaceutical expenditure by districts in Uganda and implications for budget setting and allocationWhich patients are prescribed inhaled anti-asthma drugs?Socioeconomic determinants of rates of consultation in general practice based on fourth national morbidity survey of general practicesPerceptions of the impact of primary care organizations on GP prescribing: the iron fist in the velvet glove?Influences of practice characteristics on prescribing in fundholding and non-fundholding general practices: an observational study.Review of prescribed treatment for children with asthma. Weaknesses in methods and analysis limit conclusions.Prescribing costs. Weighting allowance insufficient.Influences of practice characteristics on prescribing in practices. Multiple regression models depend on explanatory variables included.Prescribing costs: Contribution of prepayment certificates.Review of prescribed treatment for children with asthma: Author’s reply.The effect of doctor ethnicity and country of qualification on prescribing patterns: an ecological study.Prescribing costs in UK general practice: the impact of hard budget constraints
P2860
Q24804642-105636BF-D970-4049-8E43-AD0A5DEE423EQ33177370-338FF8D6-8A76-443B-B380-368EA524EC08Q33572762-78CE3B7E-34F6-41A3-AB6D-53CFFF2483CDQ33789278-BD2C919C-34B1-45B4-82D6-6A85C671077DQ34052784-5F5FAF44-9B27-47E4-91B3-9C1A68944BA1Q34054520-C03032A4-36C9-43BE-AE19-45C1181C3336Q34217635-59D08894-D0A6-4914-BFA0-6CC360200AD9Q34218020-CA280A71-BFB9-4DF4-A9C6-D9D08434C030Q35061584-D2700500-28F9-4B60-9594-80ABA88673DCQ35124524-581A0076-6955-4833-91F7-C4E3129B2929Q35166628-ED2B0000-5BD0-4846-AB5F-C8455C6C3FC3Q35414428-350AC199-5F16-4445-A996-5434F769B291Q35750896-ED78F4A2-A518-485E-AE12-F55CC54DBDD4Q36577407-9659BFF7-BC10-4D76-ADB5-2DDEB24EA4E1Q36598203-E01D34A8-D899-4A66-81DC-16E3D66B0381Q39795026-2D98315E-3FE8-4E3E-B4C9-A21124DE637DQ41833748-4E007901-2032-45D0-8261-F0E0A8F90BF6Q42916186-B6FE8F33-5A91-4B98-88A5-8EDC297E7868Q43151853-C8D5D77B-BEA8-48BE-A559-E4A906CAB094Q43191205-F2F679D4-FA99-44E6-AED6-ACF3C90B224AQ45977968-0D036772-EFE9-44CD-8AE0-B7B21584638CQ46392098-6434ED90-23D2-422B-AD01-A015E57299E6Q51204970-2F44F717-2F3A-4BF5-8032-BCA6E77559E5Q58259860-6FB06BCF-C713-4FCD-90AA-8188F9F4E79C
P2860
Explaining variations in prescribing costs across England.
description
1993 nî lūn-bûn
@nan
1993 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Explaining variations in prescribing costs across England.
@ast
Explaining variations in prescribing costs across England.
@en
type
label
Explaining variations in prescribing costs across England.
@ast
Explaining variations in prescribing costs across England.
@en
prefLabel
Explaining variations in prescribing costs across England.
@ast
Explaining variations in prescribing costs across England.
@en
P2860
P1433
P1476
Explaining variations in prescribing costs across England.
@en
P2093
Morton-Jones T
P2860
P304
P356
10.1136/BMJ.306.6894.1731
P407
P577
1993-06-01T00:00:00Z